MacroGenics
MGNX
#8794
Rank
NZ$0.42 B
Marketcap
NZ$6.66
Share price
5.35%
Change (1 day)
125.68%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): NZ-$0.93

According to MacroGenics's latest financial reports the company's current EPS (TTM) is NZ-$1.02. In 2025 the company made an earnings per share (EPS) of NZ-$2.10 a decrease over its 2024 EPS that were of NZ-$1.91.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.93-55.71%
2025NZ-$2.1010.28%
2024NZ-$1.91613.33%
2023NZ-$0.27-92.31%
2022NZ-$3.47-42.14%
2021NZ-$6.0136.44%
2020NZ-$4.40-21.84%
2019NZ-$5.63-24.58%
2018NZ-$7.47675.93%
2017NZ-$0.96-68.05%
2016NZ-$3.01168.25%
2015NZ-$1.12-55%
2014NZ-$2.493400%
2013NZ-$0.07128-108.68%
2012NZ$0.8224.49%
2011NZ$0.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.35-233.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.25-5,342.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$28.90-2,945.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ-$4.63 356.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.26-322.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.09-896.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ-$3.87 280.70%๐Ÿ‡บ๐Ÿ‡ธ USA